Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Operating Leases: 2019-2024

Historic Operating Leases for Veracyte (VCYT) over the last 6 years, with Dec 2024 value amounting to $43.2 million.

  • Veracyte's Operating Leases rose 105.41% to $40.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year increase of 105.41%. This contributed to the annual value of $43.2 million for FY2024, which is 474.58% up from last year.
  • Latest data reveals that Veracyte reported Operating Leases of $43.2 million as of FY2024, which was up 474.58% from $7.5 million recorded in FY2023.
  • In the past 5 years, Veracyte's Operating Leases registered a high of $43.2 million during FY2024, and its lowest value of $7.5 million during FY2023.
  • For the 3-year period, Veracyte's Operating Leases averaged around $20.5 million, with its median value being $10.6 million (2022).
  • Per our database at Business Quant, Veracyte's Operating Leases fell by 29.33% in 2023 and then skyrocketed by 474.58% in 2024.
  • Over the past 5 years, Veracyte's Operating Leases (Yearly) stood at $9.9 million in 2020, then skyrocketed by 42.14% to $14.1 million in 2021, then dropped by 24.46% to $10.6 million in 2022, then declined by 29.33% to $7.5 million in 2023, then soared by 474.58% to $43.2 million in 2024.